Kennedy Capital Management Inc. lessened its position in Invacare Co. (NYSE:IVC) by 75.1% during the first quarter, Holdings Channel reports. The fund owned 539,991 shares of the health services provider’s stock after selling 1,632,588 shares during the period. Kennedy Capital Management Inc.’s holdings in Invacare were worth $4,520,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Citigroup Inc. increased its stake in shares of Invacare by 415.9% during the first quarter. Citigroup Inc. now owns 20,089 shares of the health services provider’s stock valued at $168,000 after purchasing an additional 16,195 shares in the last quarter. Elk Creek Partners LLC increased its stake in shares of Invacare by 2.4% during the first quarter. Elk Creek Partners LLC now owns 3,177,507 shares of the health services provider’s stock valued at $26,596,000 after purchasing an additional 73,599 shares in the last quarter. Swiss National Bank increased its stake in shares of Invacare by 5.6% during the first quarter. Swiss National Bank now owns 60,500 shares of the health services provider’s stock valued at $506,000 after purchasing an additional 3,200 shares in the last quarter. Wells Fargo & Company MN increased its stake in shares of Invacare by 579.6% during the first quarter. Wells Fargo & Company MN now owns 393,133 shares of the health services provider’s stock valued at $3,290,000 after purchasing an additional 335,287 shares in the last quarter. Finally, BlackRock Inc. increased its stake in shares of Invacare by 4.2% during the first quarter. BlackRock Inc. now owns 4,921,225 shares of the health services provider’s stock valued at $41,190,000 after purchasing an additional 198,981 shares in the last quarter.

IVC has been the subject of a number of analyst reports. ValuEngine downgraded shares of Invacare from a “hold” rating to a “sell” rating in a research note on Wednesday, May 1st. Needham & Company LLC reaffirmed a “buy” rating and set a $15.00 target price on shares of Invacare in a research note on Thursday, February 14th. Finally, Zacks Investment Research raised shares of Invacare from a “hold” rating to a “strong-buy” rating and set a $11.00 target price for the company in a research note on Thursday, February 21st.

Shares of IVC traded down $0.08 on Wednesday, hitting $5.12. 3,016 shares of the stock traded hands, compared to its average volume of 720,817. The company has a market capitalization of $181.99 million, a P/E ratio of -3.83 and a beta of 2.29. The company has a quick ratio of 1.29, a current ratio of 1.97 and a debt-to-equity ratio of 0.78. Invacare Co. has a one year low of $3.05 and a one year high of $20.00.

Invacare (NYSE:IVC) last announced its quarterly earnings results on Monday, May 6th. The health services provider reported ($0.32) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.33) by $0.01. The company had revenue of $223.40 million during the quarter, compared to the consensus estimate of $229.93 million. Invacare had a negative net margin of 4.56% and a negative return on equity of 11.69%. The firm’s quarterly revenue was down 5.8% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.35) earnings per share. On average, sell-side analysts expect that Invacare Co. will post -1.03 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, July 22nd. Investors of record on Friday, July 5th will be given a dividend of $0.0125 per share. This represents a $0.05 annualized dividend and a dividend yield of 0.98%. The ex-dividend date is Wednesday, July 3rd. Invacare’s dividend payout ratio (DPR) is currently -3.79%.

COPYRIGHT VIOLATION NOTICE: This article was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.watchlistnews.com/invacare-co-nyseivc-shares-sold-by-kennedy-capital-management-inc/3039387.html.

Invacare Company Profile

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments.

Featured Story: 52-Week High/Low Prices For Stock Selection

Want to see what other hedge funds are holding IVC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invacare Co. (NYSE:IVC).

Institutional Ownership by Quarter for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.